ITALY, Torino, December, 15th, 2020. ELITechGroup is pleased to announce the release of SARS-CoV-2 PLUS ELITe MGB® Kit. The Kit is CE-IVD marked and detects SARS-CoV-2, Flu A, Flu B, and RSV on the Sample-to Result-Platform ELITe InGenius® and is available on major PCR thermocyclers as well. The test will complement the menu of 41 CE-IVD certified infectious disease tests on ELITe InGenius® and specifically the panel for the respiratory infections. The SARS-CoV-2 PLUS test was developed to provide a differential diagnosis to distinguish SARS-CoV-2 from other respiratory viruses that may give similar symptoms. The kit detects Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Influenza A Virus (FluA), Influenza B Virus (FluB), Respiratory Syncytial Virus type A and type B (RSV). The endogenous Internal Control allows confirming the presence and quality of the sample material extracted.
Roberto Meda, Vice President MDx ELITechGroup, is excited to offer such an important multiplex Sample-to-Result solution for the detection of the SARS-CoV-2, Flu A, Flu B, and RSV viruses. This achievement was made possible by the dedication and collaboration of all EG teams involved.
About ELITechGroup: ELITechGroup is a privately held group of worldwide manufacturers and distributors of in vitro diagnostic equipment and reagents. By bringing together IVD specialty companies that offer innovative products and solutions, ELITechGroup has become a major contributor in advancing clinical diagnostics to laboratories in the proximity market, those operating closer to the patient.